Graham Corporation — Form 10-Q Summary
Reporting period: Three months ended June 30, 2013, the first quarter of fiscal 2014. The request metadata identifies “2012 Q1,” but the supplied filing is for June 30, 2013, with comparison to June 30, 2012.
Business Context
Graham designs and manufactures custom-engineered equipment for refining, petrochemical, chemical, power, nuclear, defense, and other industrial applications. Operations include facilities in New York and Michigan and a wholly owned engineering and sales subsidiary in China. Management described market conditions as improving, with stronger bidding activity and an expanding project pipeline.
Key Financial Metrics
| Metric | Q1 FY2014 | Q1 FY2013 | Change |
|---|---|---|---|
| Net sales | $28.256 million | $22.533 million | +25% |
| Gross profit | $10.015 million | $6.236 million | +61% |
| Gross margin | 35% | 28% | +7 percentage points |
| Operating margin | 20% | 10% | +10 percentage points |
| Income before taxes | $5.618 million | $2.083 million | +170% |
| Net income | $3.808 million | $1.390 million | +174% |
| Diluted EPS | $0.38 | $0.14 | +171% |
| Operating cash flow | $2.000 million | $5.477 million | Down $3.477 million |
SG&A was $4.403 million, or 16% of sales, compared with $4.084 million, or 18%, in the prior-year quarter. The effective tax rate was 32%, compared with 33%. Interest expense declined to $5,000 from $80,000, primarily because of lower interest related to uncertain tax positions.
At June 30, 2013, cash and cash equivalents were $25.693 million and short-term investments were $27.499 million, for total cash and investments of $53.192 million. Working capital was $68.352 million, with a current ratio of 3.8. The company had no borrowings under its revolving credit facility; $7.694 million of letters of credit were outstanding, leaving reported availability of $17.306 million. Capital lease obligations totaled $193,000.
Material Changes Versus the Prior Comparable Period
- Sales growth was driven by higher volume in the refining and power markets. International sales increased 34%, primarily from refining activity in China, while domestic sales increased 19%.
- Sales mix shifted materially: refining represented 45% of sales versus 23% previously; chemical and petrochemical sales were 16% versus 25%; power was 27% versus 23%; and other applications were 12% versus 29%.
- Gross margin improved because of higher volume, greater capacity utilization, stronger pricing on short-cycle sales, and conversion of projects with more favorable pricing.
- Operating cash flow declined because higher sales and the timing of progress-payment invoices increased accounts receivable. This was partly offset by higher net income, lower inventory, and higher customer deposits.
- Orders increased 66% to $32.783 million from $19.721 million. Domestic orders represented 87% of current-quarter orders, compared with 41% in the prior-year quarter.
- Backlog increased 5% to $90.382 million from $85.768 million at March 31, 2013. Approximately 70% to 75% of backlog was expected to convert to sales within twelve months.
- Dividends paid increased to $301,000 from $200,000, following a 50% increase in dividends per share announced in January 2013.
Cash Flow, Capital Spending, and Liquidity
- Net cash used in investing activities was $294,000, including $295,000 of capital expenditures and largely offsetting purchases and maturities of short-term U.S. Treasury investments.
- Net cash used in financing activities was $213,000, primarily dividends and capital lease repayments.
- Cash and cash equivalents increased $1.499 million during the quarter to $25.693 million.
- Fiscal 2014 capital expenditures were expected to be approximately $3.5 million to $4.5 million, subject to market conditions, with 75% to 85% directed to machinery and equipment.
- Management expected fiscal 2014 cash flow to be positive, driven primarily by net income and partly offset by capital spending and limited additional working-capital needs.
Guidance, Outlook, Risks, and Unusual Items
- Fiscal 2014 revenue guidance was approximately $100 million to $115 million, representing a 5% decrease to a 10% increase versus fiscal 2013.
- Fiscal 2014 gross margin was expected to range from 29% to 31%, SG&A was expected to be 15% to 16% of sales, and the effective tax rate was expected to be 33% to 34%.
- Management expected continued market recovery in refining and petrochemicals, renewed U.S. petrochemical investment supported by lower natural-gas costs, and opportunities in nuclear, power, and U.S. Navy projects.
- Management cautioned that order timing may remain volatile and that the strong first-quarter domestic order mix was not yet evidence of a permanent market shift.
- Conversion of U.S. Navy and two large nuclear projects was expected to contribute significantly to fiscal 2014 results. Delays could negatively affect revenue and earnings.
- Emerging-market growth may create pricing and gross-margin pressure. Management also cited foreign-currency exposure, materials-price volatility, competition, project cancellation or delay, customer concentration by project timing, and cyclical end markets.
- The company was defending asbestos-related personal-injury lawsuits and other ordinary-course claims. Management could not estimate a reasonably possible loss range but did not expect a material effect on results, financial position, or cash flows.
- A $20,000 reversal of product-warranty provisions was recorded because of lower claims experience. Warranty liability was $331,000 at June 30, 2013, versus $194,000 a year earlier.
- The company made no defined-benefit pension contributions during the quarter and did not expect contributions for the balance of fiscal 2014. It expected approximately $107,000 of postretirement benefit payments during the balance of the year.
- Management stated that there were no off-balance-sheet arrangements other than operating leases and letters of credit, no projects on hold, and effective disclosure controls.
Important Facts for Investors to Verify
- Reconcile the requested “2012 Q1” period with the actual June 30, 2013 filing period.
- Monitor conversion of the $90.382 million backlog into revenue, particularly the U.S. Navy and two large nuclear projects.
- Assess whether the first-quarter 35% gross margin can normalize within management’s 29% to 31% fiscal-year guidance.
- Track accounts receivable, progress-payment timing, and operating cash flow, which declined despite substantially higher earnings.
- Evaluate order volatility and whether the unusually high 87% domestic order mix persists.
- Review exposure to project delays or cancellations, commodity-price pressure, foreign competition, emerging-market pricing, and nuclear-market uncertainty.
- Review the asbestos litigation and other contingencies, noting that the filing provides no estimable reasonably possible loss range.